Triad Wealth Partners’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Buy
9,053
+239
+3% +$5.7K 0.01% 531
2026
Q1
$210K Buy
+8,814
New +$212K 0.02% 465

Other funds holding IBD

Triad Wealth Partners's IBD Position: Q2 2026 in Review

Triad Wealth Partners increased its Inspire Corporate Bond ETF (IBD) stake by 2.7% in Q2 2026, buying an estimated $5.7K and bringing the position to 9,053 shares worth $214K. The position accounts for 0.01% of the portfolio, ranked #531.

Triad Wealth Partners first reported a position in IBD in Q1 2026 and has held it in 2 quarters since. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Triad Wealth Partners held 9,053 shares of Inspire Corporate Bond ETF worth $214K as of Q2 2026.
  • Triad Wealth Partners bought 239 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $5.7K.
  • Inspire Corporate Bond ETF made up 0.01% of Triad Wealth Partners's portfolio in Q2 2026, its #531 holding.
  • Triad Wealth Partners first reported a position in Inspire Corporate Bond ETF in Q1 2026 and has held it in 2 quarters since.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Triad Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.